Humedix gets gov't OK for trials of dementia candidate drug

South Korea’s Humedix Co., a developer of biological and pharmaceutical products, on Tuesday said it received approval from the Ministry of Fo...

Ildong Pharma to spin off R&D subsidiary in Nov

South Korea’s Ildong Pharmaceutical Co. will spin off its research and development (R&D) unit into the subsidiary Yunovia from Nov. 1.&nbs...

Daewon Pharma to export $3 mn worth of Pelubi to Indonesia

South Korea's Daewon Pharmaceutical Co. will export its nonsteroidal anti-inflammatory drug (NSAID) Pelubi to the Indonesian market. It's South Kore...

JW Pharma to conduct Phase 3 trials in Thailand for gout treatment

South Korea's JW Pharmaceutical Corp. on Thursday said it received approval from Thailand's Food and Drug Administration to conduct Phase 3 clinical...

Daewoong to develop eye drops for diabetic retinopathy

South Korea's Daewoong Pharmaceutical is venturing into the development of a product that can easily treat diabetic retinopathy in the form of ...

LG Chem opens European CS Center in Germany

South Korea's top chemical company LG Chem Ltd. announced the opening of its European Customer Solution Center (CS Center) in Frankfurt on Wednesday...

Daewoong gets patent of Nabota as migraine drug in US

South Korea's Daewoong Pharmaceutical Co. announced on Thursday that it has received a patent from the US Patent and Trademark Office for the use of...

JW Pharma to participate in S.Korea’s new drug project

South Korea's JW Pharmaceutical announced on Monday that its experimental hair loss drug, JW0061, has been selected for a two-year funding program b...

EuBiologics, GC Biopharma to jointly produce cholera vaccine

South Korea's EuBiologics Co., the world's leading cholera vaccine company, has signed a joint production agreement with GC Biopharma Corp. to produ...

Daewoong applies for approval of Envlo in Saudi Arabia

South Korea's Daewoong Pharmaceutical Co. announced on Friday that it has submitted an application for regulatory approval of its new diabetes treat...

DongKoo Bio & Pharma to enter Philippine healthcare market

South Korea’s DongKoo Bio & Pharma Co. on Tuesday said it signed a memorandum of understanding with the Philippine healthcare group Adizat...

Ildong Pharma to export high blood pressure treatment to China

South Korea's Ildong Pharmaceutical Co. on Tuesday said it will export benidipine hydrochloride, a raw material used in the treatment of high blood ...

JW Pharma gets OK for phase 3 clinical trials of URC102 in Taiwan

South Korea's JW Pharmaceutical has won approval from Taiwan's Food and Drug Administration (TFDA) to conduct phase 3 clinical trials for its gout t...

SK Pharmteco secures 12 global pharma clients, sets up US R&D center

SK Pharmteco Co., South Korean conglomerate SK Group’s contract development and manufacturing organization (CDMO), has secured 12 global pharm...

Dongwha Pharm to buy Vietnamese pharmacy chain at $30 mn

South Korea's Dongwha Pharm announced on Thursday that it signed an agreement to acquire a 51% stake in Trung Son Pharma, a leading pharmacy chain i...

Daewoong launches GERD treatment Fexuclu in Philippines

South Korea's Daewoong Pharmaceutical announced on Tuesday that it has launched the GERD treatment drug "Fexuclue" (active ingredient: Fexuprazan) i...

Boryung Pharma's sales surpass $311 mn in H1 2023

South Korea’s Boryung Corp. has alleviated the fear of falling behind in its sector expressed by its third-generation chairman Jay Kim Jung-Gy...

Kolon Pharma, Dongbang Medical to export medical threads to Brazil

Kolon Pharma, the pharmaceutical affiliate of South Korea's Kolon Group, announced on Thursday that it has signed a business agreement with Dongbang...

CJ Logistics to enter global pharmaceutical transportation market

South Korea’s CJ Logistics on Wednesday said it obtained the certification CEIV Pharma, or the Center of Excellence for Independent Validators...

ISTE to develop eco-friendly hydrogen with British company

An innovative South Korean small business has secured technology to simultaneously produce eco-friendly hydrogen and cathode materials for secondary...

Daewoong's Nabota exceeds 600,000 customers in US

South Korea's Daewoong Pharmaceutical said on Thursday that its local loyalty program for Nabota (American name: Jeuveau) in the US, a botulinum tox...

JW Pharma unveils S.Korea's first homegrown hybrid incubator

South Korea's JW Pharmaceutical on Wednesday released three products from its new incubator brand Hi-Mammi.The company's rollout of hybrid and high-...

Rolls-Royce unveils its first all-electric model, Spectre, in Seoul

Rolls-Royce has unveiled Spectre, the brand's first all-electric model, on Friday in Seoul for the first time in the Asia-Pacific region.The exterio...

S.Korea’s top pharmaceutical distributor buys 25% of No. 2 Baekje Pharma

South Korea’s top pharmaceutical distributor Geo-young Co. has acquired 25% of market No. 2 Baekje Pharmaceutical.Geo-young on Tuesday said th...

HanAll, Daewoong to develop Parkinson's treatment with US partner

South Korea's HanAll Biopharma Co. and Daewoong Pharmaceutical on Thursday said they concluded a contract with NurrOn Pharmaceuticals of the US on...

Daewoong Pharmaceutical’s cumulative tech exports exceed $870 mn

South Korea’s Daewoong Pharmaceutical said on Friday that it had concluded three technology export agreements for new drugs and new drug candi...

Daewoong Pharma to build third botulinum toxin plant for $746 mn

South Korea’s Daewoong Pharmaceutical next year will open a third plant to greatly expand annual output of its botulinum toxin Nabota at a cos...

Daewoong to transfer techs for autoimmune disease to US pharma

South Korea's Daewoong Pharmaceutical announced on Friday that it has signed a technology export contract for the clinical development and commercia...

S.Korea's Kainos Medicine exports AIDS treatment technology to China

South Korean new drug developer Kainos Medicine Inc. announced on Friday that it had signed a technology transfer agreement with Chinese pharmaceuti...

MBK Partners to buy Belgian chocolate brand Pierre Marcolini

Private equity firm MBK Partners is set to acquire Pierre Marcolini, a Belgian chocolate brand called "Hermes of Chocolate."MBK bought the South Kor...